David van der Poorten

Author

Also Known As

D van der Poorten, D. VAN DER POORTEN, D. Van Der Poorten, D. Van der Poorten, D. van der Poorten, David Poorten, David Van Der Poorten, David Van der Poorten, David van der Poorten, Van der Poorten, D.

Publications

3.1K

Citations

H-Index

Concepts

All Affiliations

The University of Sydney Westmead Hospital Westmead Institute Westmead Institute for Medical Research Millennium Institute

About

David van der Poorten is an author at The University of Sydney specializing in medicine, hepatology, and liver physiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	391
2	Health Sciences	3	3	211
3	Cell Biology	2	2	76
4	Natural Sciences	1	1	20
5	Allergy	1	1	17

David van der Poorten

Publications

2.9K

Citations

H-Index

Page 1

	Year	Citations
Visceral fat David van der Poorten, Kerry–Lee Milner, Jason M. Hui, Hepatology	2008	597
The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: An international collaborative study Neeraj Bhala, Paul Angulo, David van der Poorten, Hepatology	2011	449
Hepatic fat loss in advanced nonalcoholic steatohepatitis: Are alterations in serum adiponectin the cause? David van der Poorten, Caroline Samer, Mehdi Ramezani–Moghadam, Hepatology	2012	176
Adipocyte fatty acid binding protein levels relate to inflammation and fibrosis in nonalcoholic fatty liver disease† Kerry–Lee Milner, David van der Poorten, Aimin Xu, Hepatology	2009	171
Complex non‐invasive fibrosis models are more accurate than simple models in non‐alcoholic fatty liver disease Leon A. Adams, Jacob George, Elisabetta Bugianesi, Journal of Gastroenterology and Hepatology	2011	170
Chronic Hepatitis C Is Associated With Peripheral Rather Than Hepatic Insulin Resistance Kerry–Lee Milner, David van der Poorten, Michael I. Trenell, Gastroenterology Metabolic SyndromeHepatologyHepatitis CViral HepatitisLiver Physiology	2009	131
MBOAT7 rs641738 increases risk of liver inflammation and transition to fibrosis in chronic hepatitis C Khaled Thabet, Anastasia Asimakopoulos, Maryam Shojaei, Nature Communications	2016	127
Diverse impacts of the rs58542926 E167K variant in TM6SF2 on viral and metabolic liver disease phenotypes Mohammed Eslam, Alessandra Mangia, Thomas Berg, Hepatology	2016	113
Twenty‐year audit of percutaneous liver biopsy in a major Australian teaching hospital David van der Poorten, Avelyn Kwok, Thomas Lam, Internal Medicine Journal	2006	104
Midkine Increases Diagnostic Yield in AFP Negative and NASH-Related Hepatocellular Carcinoma Roslyn Vongsuvanh, David van der Poorten, Tristan J. Iseli, PLoS ONE	2016	70

Page 1